Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766) — Cash Flow-to-Debt Ratio
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766) has a Cash Flow-to-Debt Ratio of 0.00x as of September 2025, meaning its operating cash flow of CN¥-7.23 Million could theoretically repay 0% of its total liabilities (CN¥2.23 Billion) in one year. See Tonghua Golden-Horse Pharmaceutical Indu free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for Tonghua Golden-Horse Pharmaceutical Industry Co Ltd across 28 annual periods. Also explore 000766 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (1998–2025)
Year-by-year debt coverage analysis for Tonghua Golden-Horse Pharmaceutical Industry Co Ltd. For market capitalisation and broader financial context, see Tonghua Golden-Horse Pharmaceutical Indu stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.05x | CN¥105.05 Million | CN¥2.17 Billion | ▼ -33.6% |
| 2024 | 0.07x | CN¥162.75 Million | CN¥2.23 Billion | ▲ +42.6% |
| 2023 | 0.05x | CN¥112.78 Million | CN¥2.20 Billion | ▼ -40.1% |
| 2022 | 0.09x | CN¥198.16 Million | CN¥2.32 Billion | ▲ +42.3% |
| 2021 | 0.06x | CN¥138.33 Million | CN¥2.30 Billion | ▲ +99.3% |
| 2020 | 0.03x | CN¥80.71 Million | CN¥2.68 Billion | ▼ -18.1% |
| 2019 | 0.04x | CN¥74.86 Million | CN¥2.03 Billion | ▼ -73.0% |
| 2018 | 0.14x | CN¥170.72 Million | CN¥1.25 Billion | ▲ +576.3% |
| 2017 | 0.02x | CN¥26.43 Million | CN¥1.31 Billion | ▼ -74.5% |
| 2016 | 0.08x | CN¥90.63 Million | CN¥1.14 Billion | ▲ +194.1% |
| 2015 | -0.08x | CN¥-160.95 Million | CN¥1.91 Billion | ▼ -253.8% |
| 2014 | 0.05x | CN¥34.32 Million | CN¥626.09 Million | ▼ -73.8% |
| 2013 | 0.21x | CN¥102.96 Million | CN¥491.91 Million | ▲ +987.3% |
| 2012 | -0.02x | CN¥-6.49 Million | CN¥275.29 Million | ▲ +18.9% |
| 2011 | -0.03x | CN¥-7.93 Million | CN¥272.69 Million | ▼ -130.7% |
| 2010 | 0.09x | CN¥29.05 Million | CN¥306.71 Million | ▼ -66.2% |
| 2009 | 0.28x | CN¥79.94 Million | CN¥285.36 Million | ▲ +603.1% |
| 2008 | 0.04x | CN¥10.26 Million | CN¥257.51 Million | ▲ +9.1% |
| 2007 | 0.04x | CN¥9.95 Million | CN¥272.53 Million | ▲ +157.2% |
| 2006 | -0.06x | CN¥-18.02 Million | CN¥282.05 Million | ▼ -289.8% |
| 2005 | 0.03x | CN¥35.74 Million | CN¥1.06 Billion | ▲ +85.6% |
| 2004 | 0.02x | CN¥19.12 Million | CN¥1.05 Billion | ▼ -77.4% |
| 2003 | 0.08x | CN¥91.99 Million | CN¥1.14 Billion | ▲ +14.9% |
| 2002 | 0.07x | CN¥72.70 Million | CN¥1.04 Billion | ▲ +109.4% |
| 2001 | -0.74x | CN¥-740.34 Million | CN¥994.08 Million | ▼ -548.4% |
| 2000 | 0.17x | CN¥196.15 Million | CN¥1.18 Billion | ▲ +159.0% |
| 1999 | -0.28x | CN¥-80.62 Million | CN¥286.19 Million | ▼ -4.8% |
| 1998 | -0.27x | CN¥-62.93 Million | CN¥234.01 Million | — |